EN
HI
3B Blackbio Dx Chart
3B Blackbio Dx Share Key Metrics
Volume
8821.00
Market Cap
1113.60 CR
LTQ@LTP
1@1293.00
ATP
1285.27
Var Margin
25.76 %
Circuit Range
1038-1557
Delivery %
88.3 %
Value
1.13 CR
ASM/GSM
No
Market Lot
1
Summary
At 19 Mar, 2026 | 15:29, 3B Blackbio Dx share price stands at ₹1293, showing a 4.50% -0.35 for the day. The stock’s intraday movement has stayed between ₹1250.00 and ₹1315.00, while on a 52-week basis it has fluctuated from ₹1151.00 to ₹2019.90.
In terms of trading activity, 3B Blackbio Dx has recorded a volume of 8821 shares, with a market capitalisation of ₹8582670. The stock’s Average Traded Price (ATP) stands at ₹128527, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,129300. The stock operates within a circuit range of ₹1038-1557, with a Value of ₹1.13 CR. The Delivery Percentage for the day is 88.3%. Additionally, 3B Blackbio Dx currently falls under the No framework, and trades with a market lot size of 1.
3B Blackbio Dx Fundamentals
View MoreP/E Ratio
19.39
P/B Ratio
3.47
Div. Yield
0.31
Sector P/E
53.16
Sector P/B
2.76
Sec. Div. Yield
0.07
3B Blackbio Dx Resistance and Support
Pivot 1293.73
Resistance
First Resistance
1321.46
Second Resistance
1345.43
Third Resistance
1373.16
Support
First Support
1269.76
Second Support
1242.03
Third Support
1218.06
3B Blackbio Dx Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-06 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-28 | Audited Results & Dividend |
| 2025-02-13 | Quarterly Results |
3B Blackbio Dx News
3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
3B BlackBio Dx Ltd held an investor meeting with Fair Value Capital (India Insight Value Fund) on March 17, 2026. Only information already in the public domain, including its Q3-FY26 investor presentation, was discussed. No unpublished price sensitive information was shared during the meeting.
Mar 17 2026 17:03:00
3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
3B BlackBio Dx Ltd. hosted its Q3 FY26 earnings call, revealing nine-month revenue of ₹99.06 crores, a significant increase. The company forecasts 10-15% topline and EBITDA growth for the full year, supported by robust export performance and ongoing strategic initiatives like new product development and market penetration.
Feb 24 2026 15:02:00
Read More
About 3B Blackbio Dx
NSE : 0
BSE : 532067
ISIN : INE994E01018
& PRESENT BUSINESS OF THE COMPANYKILPEST INDIA LIMITED was incorporated as a Private LimitedCompany in the name of Kilpest Private Limited withRegistrar of Companies Madhya Pradesh at Gwalior on 27thMay 1972 and was subsequently converted into a publiclimited company on 6th March 1995.The Company is presently engaged in formulation ofpesticides.The unit was initially set up as a Small Scale Unit with asingle product which has now grown into a medium scaleunits with multiproduct range. The unit has been runningsuccessfully throughout its working in the last twodecades.The Company has an existing manufacturing capacity ofliquid (200000 Ltrs.) Dusting (2500 MT) and WDP (100 MT).The Company now proposes to expand its operation by way ofexpansion of its installed capacity and increase in productrange alongwith backward integration. It propose tomanufacture technical grade raw materials for captiveconsumption which is basic raw material for downstreampesticide items.
3B Blackbio Dx Management
| Name | Position |
|---|---|
| Mr. Dhirendra Dubey | Chairman & Managing Director |
| Mr. N K Dubey | Whole Time Director |
3B Blackbio Dx Similar Stocks
Lincoln Pharmaceuticals Ltd.
595.50
-3.30 (0.55%)
Hester Biosciences Ltd.
1426.65
21.70 (1.54%)
Bajaj Healthcare Ltd.
300.90
-8.20 (2.65%)
Syncom Formulations (India) Ltd.
11.73
-0.22 (1.84%)
GPT Healthcare Ltd.
123.75
-0.55 (0.44%)
Fermenta Biotech Ltd.
341.95
-4.10 (1.18%)
Anuh Pharma Ltd.
74.54
-2.36 (3.07%)
Laxmi Dental Ltd.
176.90
0.00 (0.00%)
Fredun Pharmaceuticals Ltd.
1619.70
4.75 (0.29%)
3B Blackbio Dx FAQs
The Buying Price of 3B Blackbio Dx share is 1293 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy 3B Blackbio Dx stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for 3B Blackbio Dx, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of 3B Blackbio Dx shares is 19.39. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio 3B Blackbio Dx shares is 3.47. Useful to assess the stock's value relative to its book value.
To assess 3B Blackbio Dx’s valuation compare Sector P/E, P/B which are 53.16 & 2.76 with sector averages, along with growth rates and financial metrics.
The Market Cap of 3B Blackbio Dx is 1113.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of 3B Blackbio Dx share price is 2019.90 & 1151.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
3B Blackbio Dx belongs to the Healthcare sector.
